PHAT R&D to Revenue
Phathom Pharmaceuticals Inc · R&D to Revenue
PHAT R&D to Revenue
Latest reported18.72%period ending
PHAT FY R&D/Revenue (0.00% → 18.72%)
Latest values, visible window
High-resolution chart · PNG
PHAT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 18.7197% | |
| 61.6846% | |
| 7,316.5689% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |